- September 2, 2022
- Newsletter
- 617-430-5616
Menu
Brand Name :
Metanx
Synonyms :
Class :
Supplements
Dosage Forms & Strengths
capsule
3mg-35mg-2mg- L-methylfolate-pyridoxal 5′-phosphate-methylcobalamine
Safety and efficacy not studied
may decrease the serum concentration of Quinolones
may decrease the serum concentration of Quinolones
may decrease the serum concentration of Quinolones
may decrease the serum concentration of Quinolones
may decrease the serum concentration of Quinolones
may diminish the serum concentration when combined with quinolones
may diminish the serum concentration when combined with quinolones
it may decrease the level of serum concentration of Multivitamins
may diminish the serum concentration of quinolones
methyldopa/hydrochlorothiazide
may diminish the serum concentration of methyldopa
may diminish the serum concentration of magnesium salts
may reduce the levels of serum concentration of multivitamins
may reduce the levels of serum concentration of multivitamins
may reduce the levels of serum concentration of multivitamins
may reduce the levels of serum concentration of multivitamins
may reduce the levels of serum concentration of multivitamins
may have an increased adverse effect when combined with vitamin D analogs
may increase the toxic effect of retinoic acid derivatives
may increase the toxic effect of Vitamin D analogs
may diminish the serum concentration of magnesium salts
aluminum hydroxide/magnesium hydroxide
may diminish the serum concentration of Aluminum Hydroxide
may increase the toxic effect when combined
it may decrease the serum concentration of Multivitamins
it may decrease the serum concentration of Multivitamins
it may decrease the serum concentration of Multivitamins
it may decrease the serum concentration of Multivitamins
it may decrease the serum concentration of Multivitamins
it may enhance the antiplatelet effect of Agents with antiplatelet Properties
it may enhance the antiplatelet effect of Agents with antiplatelet Properties
it may enhance the antiplatelet effect of Agents with antiplatelet Properties
it may enhance the antiplatelet effect of Agents with antiplatelet Properties
it may enhance the antiplatelet effect of Agents with antiplatelet Properties
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
may increase the antiplatelet effect of agents with antiplatelet properties
may increase the antiplatelet effect of agents with antiplatelet properties
may increase the antiplatelet effect of agents with antiplatelet properties
may increase the antiplatelet effect of agents with antiplatelet properties
may increase the antiplatelet effect of agents with antiplatelet properties
may decrease the levels of serum concentration of amphetamines
may decrease the levels of serum concentration of amphetamines
may decrease the levels of serum concentration of amphetamines
may decrease the levels of serum concentration of amphetamines
may decrease the levels of serum concentration of amphetamines
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
multivitamins: they may increase the antiplatelet effect of antiplatelet agents
multivitamins: they may increase the antiplatelet effect of antiplatelet agents
may increase the arrhythmogenic effect of cardiac glycosides
may increase the arrhythmogenic effect of cardiac glycosides
may increase the arrhythmogenic effect of cardiac glycosides
antacids may reduce the serum concentration of multivitamins
antacids may reduce the serum concentration of multivitamins
antacids may reduce the serum concentration of multivitamins
antacids may reduce the serum concentration of multivitamins
antacids may reduce the serum concentration of multivitamins
may decrease the serum concentration of multivitamins
may decrease the serum concentration of multivitamins
may reduce the effect of altretamine
may decrease the serum concentration
may decrease the serum concentration
may decrease the levels of serum concentration
may decrease the levels of serum concentration
may decrease the levels of serum concentration
may decrease the levels of serum concentration
It may enhance the risk of adverse effects when combined with vitamins
It may enhance the risk of adverse effects when combined with vitamins
It may enhance the risk of adverse effects when combined with vitamins
It may enhance the risk of adverse effects when combined with vitamins
It may enhance the risk of adverse effects when combined with vitamins
may diminish the serum concentration when combined with multivitamins/fluoride
Adverse drug reactions:
Frequency Not Defined
Nausea
Vomiting
Transitory exanthema
Abdominal pain
Allergic reactions
Loss of appetite
Paresthesia
Somnolence
Nausea
Headaches
Itching
Edema
Pregnancy warnings:
Pregnancy Category: C
Breastfeeding warnings:
The release of the drug into the human breastmilk is unknown
Pregnancy Categories:
Patient Information Leaflet
Generic Name: L-methylfolate/pyridoxal 5′-phosphate/methylcobalamin
Why do we use L-methylfolate/pyridoxal 5′-phosphate/methylcobalamin?
L-methylfolate/pyridoxal 5’phosphate/methylcobalamin belongs to the class supplements used to treat Diabetic Peripheral Neuropathy